Cytori Therapeutics buy marge
Start price
13.04.17
/
50%
?0.97
Target price
03.01.18
€1.80
Performance (%)
-73.76%
End price
03.01.18
€0.25
Summary
This prediction ended on 03.01.18 with a price of €0.25. Massive losses of -73.76% were the result for the BUY prediction by marge. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cytori Therapeutics | - | - | - | - |
| iShares Core DAX® | -1,74 % | 5,98 % | 8,98 % | 49,86 % |
| iShares Nasdaq 100 | 2,81 % | 11,83 % | 38,41 % | 100,33 % |
| iShares Nikkei 225® | -0,11 % | 11,69 % | 46,68 % | 65,35 % |
| iShares S&P 500 | 0,97 % | 7,62 % | 28,14 % | 68,66 % |
Comments by marge for this prediction
In the thread Cytori Therapeutics diskutieren
marge stimmt der Buy-Einschätzung von zeckenjoe zu
Cytori Therapeutics (CYTX) announces that the FDA has approved an Investigational Device Exemption
(IDE) for a pilot clinical trial to evaluate Cytori Cell Therapy in patients with thermal burn injury,
with shares ahead 23% premarket, and announced 10.04 that it intends to offer and sell shares of its common stock in an underwritten public offering, with shares down -36%.
Trading hoch 3
(Vom Mitglied beendet)